EndoCare's Cryocare Gets National Medicare Coverage Nod From HCFA
This article was originally published in The Gray Sheet
Executive Summary
The Health Care Financing Administration will allow Medicare payment for cryosurgery for prostate cancer, citing data submitted by EndoCare, maker of the Cryocare system for cryosurgical ablation, the company reports.
You may also be interested in...
Endocare And Galil Relations Cold As Prostate Cryosurgery Market Heats Up
The number of cryoablation procedures to treat prostate cancer is expected to grow more than 100% over the next year, fueled by favorable outcomes from a five-year study evaluating Endocare's Cryocare system, the company predicts.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.